Prenatal exposure to perfluorinated chemicals and neurodevelopment in early infancy: The Hokkaido Study

Science of the Total Environment

Volumn 541, Issue , 2016, Pages 1002-1010

  Goudarzi, Houman ^a   Nakajima, Sonomi ^b   Ikeno, Tamiko ^a   Sasaki, Seiko ^c   Kobayashi, Sachiko ^a   Miyashita, Chihiro ^a   Ito, Sachiko ^a   Araki, Atsuko ^a   Nakazawa, Hiroyuki ^d   Kishi, Reiko ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d HOSHI UNIVERSITY   (Japan)

Author keywords

Birth cohort; Infants; Neurodevelopment; Perfluorinated chemicals

Indexed keywords

ANIMALS; CHEMICALS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

BIRTH COHORT; CONFIDENCE INTERVAL; EPIDEMIOLOGICAL STUDIES; INFANTS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; NEURODEVELOPMENT; PERFLUORINATED CHEMICALS; PERFLUOROOCTANE SULFONATES;

CHROMATOGRAPHY;

COHORT ANALYSIS; CONCENTRATION (COMPOSITION); EPIDEMIOLOGY; NEONATE; NEUROLOGY; PERSISTENT ORGANIC POLLUTANT; POLLUTION EXPOSURE; TOXICITY;

HOKKAIDO; JAPAN;

ANIMALIA;

ALKANESULFONIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; POLLUTANT;

CHEMICALLY INDUCED; COHORT ANALYSIS; FEMALE; FETUS BLOOD; GROWTH, DEVELOPMENT AND AGING; HUMAN; INFANT; JAPAN; MALE; MATERNAL EXPOSURE; METABOLISM; NERVOUS SYSTEM; POLLUTANT; PREGNANCY; PRENATAL EXPOSURE; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

ALKANESULFONIC ACIDS; CAPRYLATES; COHORT STUDIES; ENVIRONMENTAL POLLUTANTS; FEMALE; FETAL BLOOD; FLUOROCARBONS; HUMANS; INFANT; JAPAN; MALE; MATERNAL EXPOSURE; NERVOUS SYSTEM; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES;

EID: 84944088739     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2015.10.017     Document Type: Article

References (46)

1. Adinolfi M. The development of the human blood-CSF-brain barrier. Dev. Med. Child. Neurol. 1985, 27(4):532-537.
2. Anme T., Shimada C., Katayama H. Evaluation of environmental stimulation for 18 months and the realted factors. Jpn J. Publ. Health 1997, 44. [in Japanese], 364-352.
3. Augustyniak M., Mrozek-Budzyn D., Kieltyka A., Majewska R. Stability of the mental and motor Bayley Scales of Infant Development (2nd Ed.) in infants over first three years of life. Przegl. Epidemiol. 2013, 67(3):483-486. 581-4.
4. Beesoon S., Webster G.M., Shoeib M., Harner T., Benskin J.P., Martin J.W. Isomer profiles of perfluorochemicals in matched maternal, cord, and house dust samples: manufacturing sources and transplacental transfer. Environ. Health Perspect. 2011, 119:1659-1664.
5. Berg V., Nost T.H., Hansen S., Elverland A., Veyhe A.S., Jorde R., et al. Assessing the relationship between perfluoroalkyl substances, thyroid hormones and binding proteins in pregnant women; a longitudinal mixed effects approach. Environ. Int. 2015, 77:63-69.
6. Bogdanska J., Borg D., Sundstrom M., Bergstrom U., Halldin K., Abedi-Valugerdi M., et al. Tissue distribution of (3)(5)s-labelled perfluorooctane sulfonate in adult mice after oral exposure to a low environmentally relevant dose or a high experimental dose. Toxicology 2011, 284:54-62.
7. Chen M.H., Ha E.H., Wen T.W., Su Y.N., Lien G.W., Chen C.Y., et al. Perfluorinated compounds in umbilical cord blood and adverse birth outcomes. PLoS One 2012, 7:e42474.
8. Chen M.H., Ha E.H., Liao H.F., Jeng S.F., Su Y.N., Wen T.W., et al. Perfluorinated compound levels in cord blood and neurodevelopment at 2years of age. Epidemiology 2013, 24:800-808.
9. Christiansen K., Knussmann R. Sex hormones and cognitive functioning in men. Neuropsychobiology 1987, 18(1):27-36.
10. Darrow L.A., Stein C.R., Steenland K. Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the mid-Ohio valley, 2005-2010. Environ. Health Perspect. 2013, 121:1207-1213.
11. Darrow L.A., Howards P.P., Winquist A., Steenland K. Pfoa and pfos serum levels and miscarriage risk. Epidemiology 2014, 25:505-512.
12. Fei C., McLaughlin J.K., Lipworth L., Olsen J. Prenatal exposure to perfluorooctanoate (pfoa) and perfluorooctanesulfonate (pfos) and maternally reported developmental milestones in infancy. Environ. Health Perspect. 2008, 116:1391-1395.
13. Fei C., Olsen J. Prenatal exposure to perfluorinated chemicals and behavioral or coordination problems at age 7years. Environ. Health Perspect. 2011, 119:573-578.
14. Fromme H., Tittlemier S.A., Volkel W., Wilhelm M., Twardella D. Perfluorinated compounds-exposure assessment for the general population in western countries. Int. J. Hyg. Environ. Health 2009, 212:239-270.
15. Hackman D.A., Farah M.J. Socioeconomic status and the developing brain. Trends Cogn. Sci. 2009, 13(2):65-73.
16. Halldorsson T.I., Rytter D., Haug L.S., Bech B.H., Danielsen I., Becher G., et al. Prenatal exposure to perfluorooctanoate and risk of overweight at 20years of age: a prospective cohort study. Environ. Health Perspect. 2012, 120:668-673.
17. Inoue K., Okada F., Ito R., Kato S., Sasaki S., Nakajima S., et al. Perfluorooctane sulfonate (pfos) and related perfluorinated compounds in human maternal and cord blood samples: assessment of pfos exposure in a susceptible population during pregnancy. Environ. Health Perspect. 2004, 112:1204-1207.
18. Ji K., Kim S., Kho Y., Paek D., Sakong J., Ha J., et al. Serum concentrations of major perfluorinated compounds among the general population in Korea: dietary sources and potential impact on thyroid hormones. Environ. Int. 2012, 45:78-85.
19. Johansson N., Fredriksson A., Eriksson P. Neonatal exposure to perfluorooctane sulfonate (pfos) and perfluorooctanoic acid (pfoa) causes neurobehavioural defects in adult mice. Neurotoxicology 2008, 29:160-169.
20. Johansson N., Eriksson P., Viberg H. Neonatal exposure to pfos and pfoa in mice results in changes in proteins which are important for neuronal growth and synaptogenesis in the developing brain. Toxicol. Sci. 2009, 108:412-418.
21. Kato K., Calafat A.M., Needham L.L. Polyfluoroalkyl chemicals in house dust. Environ. Res. 2009, 109:518-523.
22. Kishi R., Sasaki S., Yoshioka E., Yuasa M., Sata F., Saijo Y., et al. Cohort profile: the Hokkaido study on environment and children's health in Japan. Int. J. Epidemiol. 2011, 40:611-618.
23. Knox S.S., Jackson T., Javins B., Frisbee S.J., Shankar A., Ducatman A.M. Implications of early menopause in women exposed to perfluorocarbons. J. Clin. Endocrinol. Metab. 2011, 96:1747-1753.
24. Lau C., Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Stanton M.E., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation. Toxicol. Sci. 2003, 74:382-392.
25. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99:366-394.
26. Lee Y.J., Kim M.K., Bae J., Yang J.H. Concentrations of perfluoroalkyl compounds in maternal and umbilical cord sera and birth outcomes in Korea. Chemosphere 2013, 90:1603-1609.
27. Liao C.Y., Li X.Y., Wu B., Duan S., Jiang G.B. Acute enhancement of synaptic transmission and chronic inhibition of synaptogenesis induced by perfluorooctane sulfonate through mediation of voltage-dependent calcium channel. Environ. Sci. Technol. 2008, 42(14):5335-5341.
28. Liew Z., Ritz B., Bonefeld-Jorgensen E.C., Henriksen T.B., Nohr E.A., Bech B.H., et al. Prenatal exposure to perfluoroalkyl substances and the risk of congenital cerebral palsy in children. Am. J. Epidemiol. 2014, 180:574-581.
29. Lung F.W., Shu B.C., Chiang T.L., Chen P.F., Lin L.L. Predictive validity of Bayley scale in language development of children at 6-36months. Pediatr. Int. 2009, 51(5):666-669.
30. Mariussen E. Neurotoxic effects of perfluoroalkylated compounds: mechanisms of action and environmental relevance. Arch. Toxicol. 2012, 86:1349-1367.
31. Monroy R., Morrison K., Teo K., Atkinson S., Kubwabo C., Stewart B., et al. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ. Res. 2008, 108:56-62.
32. Nagata C., Kabuto M., Shimizu H. Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women. Nutr. Cancer 1998, 30:21-24.
33. Nakajima S., Saijo Y., Kato S., Sasaki S., Uno A., Kanagami N., et al. Effects of prenatal exposure to polychlorinated biphenyls and dioxins on mental and motor development in Japanese children at 6months of age. Environ. Health Perspect. 2006, 114:773-778.
34. Nakata A., Saito K., Iwasaki Y., Ito R., Kishi R., Nakazawa H. Determination of perfluorinated compounds in human milk and evaluation of their transition from maternal plasma. Bunseki Kagaku 2009, 58:653.
35. Okada E., Kashino I., Matsuura H., Sasaki S., Miyashita C., Yamamoto J., et al. Temporal trends of perfluoroalkyl acids in plasma samples of pregnant women in Hokkaido, Japan, 2003-2011. Environ. Int. 2013, 60:89-96.
36. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, et al. 2007. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 115:1298-1305.
37. Reznick J.S., Corley R., Robinson J. A longitudinal twin study of intelligence in the second year. Monogr. Soc. Res. Child Dev. 1997, 62(1):i-vi.
38. Seacat A.M., Thomford P.J., Hansen K.J., Clemen L.A., Eldridge S.R., Elcombe C.R., et al. Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. Toxicology 2003, 183:117131.
39. Stein C.R., Savitz D.A., Dougan M. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am. J. Epidemiol. 2009, 170:837-846.
40. Stein C.R., Wolff M.S., Calafat A.M., Kato K., Engel S.M. Comparison of polyfluoroalkyl compound concentrations in maternal serum and amniotic fluid: a pilot study. Reprod. Toxicol. 2012, 34:312-316.
41. Stein C.R., Savitz D.A., Bellinger D.C. Perfluorooctanoate exposure in a highly exposed community and parent and teacher reports of behaviour in 6-12-year-old children. Paediatr. Perinat. Epidemiol. 2014, 28(2):146-156.
42. Thibodeaux J.R., Hanson R.G., Rogers J.M., Hrey B.E., Barbee B.E., Richards J.H., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol Sci. 2003, 74:369-381.
43. Vested A., Ramlau-Hansen C.H., Olsen S.F., Bonde J.P., Kristensen S.L., Halldorsson T.I., et al. Associations of in utero exposure to perfluorinated alkyl acids with human semen quality and reproductive hormones in adult men. Environ. Health Perspect. 2013, 121:453-458.
44. Wang F., Liu W., Jin Y., Dai J., Zhao H., Xie Q., et al. Interaction of pfos and bde-47 co-exposure on thyroid hormone levels and TH-related gene and protein expression in developing rat brains. Toxicol. Sci. 2011, 121:279-291.
45. Wang Y., Rogan W.J., Chen P.C., Lien G.W., Chen H.Y., Tseng Y.C., et al. Association between maternal serum perfluoroalkyl substances during pregnancy and maternal and cord thyroid hormones: Taiwan maternal and infant cohort study. Environ. Health Perspect. 2014, 122:529-534.
46. Washino N., Saijo Y., Sasaki S., Kato S., Ban S., Konishi K., et al. Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth. Environ. Health Perspect. 2009, 117:660-667.